Literature DB >> 21804198

Lysophosphatidic acid as the initiator of neuropathic pain.

Hiroshi Ueda1.   

Abstract

The injury-induced intense stimulation of spinal cord neurons causes lysophosphatidic acid (LPA) biosynthesis. LPA(1) receptor activation causes demyelination and sprouting of dorsal root fibers, leading to an induction of synaptic reorganization underlying allodynia, in which innocuous (tactile) stimuli cause intense pain. The LPA(1) signal also initiates the up-regulation of Ca(v)α2δ1 in dorsal root ganglion and PKCγ in the dorsal horn, underlying mechanisms for characteristic neuropathic hyperalgesia in myelinated sensory (A-type) fibers. On the other hand, the LPA(3) receptor mediates microglia activation at the early stage after nerve injury and LPA-induced LPA biosynthesis. Thus, both the LPA(1) and LPA(3) receptors play key roles in the initiation step using a feed-forward system for neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21804198     DOI: 10.1248/bpb.34.1154

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  8 in total

1.  Schwann cell LRP1 regulates remak bundle ultrastructure and axonal interactions to prevent neuropathic pain.

Authors:  Sumihisa Orita; Kenneth Henry; Elisabetta Mantuano; Kazuyo Yamauchi; Alice De Corato; Tetsuhiro Ishikawa; M Laura Feltri; Lawrence Wrabetz; Alban Gaultier; Melanie Pollack; Mark Ellisman; Kazuhisa Takahashi; Steven L Gonias; W Marie Campana
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

Review 2.  Lysophospholipids and their receptors in the central nervous system.

Authors:  Ji Woong Choi; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2012-07-31

Review 3.  Oxidized Lipids in Persistent Pain States.

Authors:  Tabea Osthues; Marco Sisignano
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

4.  Role of TRP Channels in Shaping the Gut Microbiome.

Authors:  Ravinder Nagpal; Santosh Kumar Mishra; Gagan Deep; Hariom Yadav
Journal:  Pathogens       Date:  2020-09-16

Review 5.  Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies.

Authors:  Luiz Henrique Medeiros Geraldo; Tânia Cristina Leite de Sampaio Spohr; Rackele Ferreira do Amaral; Anna Carolina Carvalho da Fonseca; Celina Garcia; Fabio de Almeida Mendes; Catarina Freitas; Marcos Fabio dosSantos; Flavia Regina Souza Lima
Journal:  Signal Transduct Target Ther       Date:  2021-02-01

Review 6.  Emerging Role of Phospholipids and Lysophospholipids for Improving Brain Docosahexaenoic Acid as Potential Preventive and Therapeutic Strategies for Neurological Diseases.

Authors:  Mayssa Hachem; Houda Nacir
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

Review 7.  Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain.

Authors:  Karen M Wagner; Aldrin Gomes; Cindy B McReynolds; Bruce D Hammock
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

8.  Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.

Authors:  Baasanjav Uranbileg; Nobuko Ito; Makoto Kurano; Daisuke Saigusa; Ritsumi Saito; Akira Uruno; Kuniyuki Kano; Hitoshi Ikeda; Yoshitsugu Yamada; Masahiko Sumitani; Miho Sekiguchi; Junken Aoki; Yutaka Yatomi
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.